Literature DB >> 29523536

Nonadministration of medication doses for venous thromboembolism prophylaxis in a cohort of hospitalized patients.

Victor O Popoola1, Brandyn D Lau2,3, Esther Tan1, Dauryne L Shaffer4, Peggy S Kraus5, Norma E Farrow1, Deborah B Hobson4, Jonathan K Aboagye1,6, Michael B Streiff7, Elliott R Haut8,9,10.   

Abstract

PURPOSE: Results of a study to characterize patterns of nonadministration of medication doses for venous thromboembolism (VTE) prevention among hospitalized patients are presented.
METHODS: The electronic records of all patients admitted to 4 floors of a medical center during a 1-month period were examined to identify patients whose records indicated at least 1 nonadministered dose of medication for VTE prophylaxis. Proportions of nonadministered doses by medication type, intended route of administration, and VTE risk categorization were compared; reasons for nonadministration were evaluated.
RESULTS: Overall, 12.7% of all medication doses prescribed to patients in the study cohort (n = 75) during the study period (857 of 6,758 doses in total) were not administered. Nonadministration of 1 or more doses of VTE prophylaxis medication was nearly twice as likely for subcutaneous anticoagulants than for all other medication types (231 of 1,112 doses [20.8%] versus 626 of 5,646 doses [11.2%], p < 0.001). For all medications prescribed, the most common reason for nonadministration was patient refusal (559 of 857 doses [65.2%]); the refusal rate was higher for subcutaneous anticoagulants than for all other medication categories (82.7% versus 58.8%, p < 0.001). Doses of antiretrovirals, immunosuppressives, antihypertensives, psychiatric medications, analgesics, and antiepileptics were less commonly missed than doses of electrolytes, vitamins, and gastrointestinal medications.
CONCLUSION: Scheduled doses of subcutaneous anticoagulants for hospitalized patients were more likely to be missed than doses of all other medication types.
Copyright © 2018 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

Entities:  

Keywords:  anticoagulants; electronic medical records; medication adherence; nonadministration; patient safety

Mesh:

Substances:

Year:  2018        PMID: 29523536     DOI: 10.2146/ajhp161057

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  4 in total

1.  Cost-Effectiveness of Betrixaban Compared with Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients with Acute Medical Illness in the United States.

Authors:  Holly Guy; Vicki Laskier; Mark Fisher; W Richey Neuman; Iwona Bucior; Steven Deitelzweig; Alexander T Cohen
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

2.  What the 2018 ASH venous thromboembolism guidelines omitted: nonadministration of pharmacologic prophylaxis in hospitalized patients.

Authors:  Oluwafemi P Owodunni; Brandyn D Lau; Michael B Streiff; Peggy S Kraus; Deborah B Hobson; Dauryne L Shaffer; Kristen L W Webster; Mujan Varasteh Kia; Christine G Holzmueller; Elliott R Haut
Journal:  Blood Adv       Date:  2019-02-26

3.  Role network measures to assess healthcare team adaptation to complex situations: the case of venous thromboembolism prophylaxis.

Authors:  Megan E Salwei; Pascale Carayon; Ann S Hundt; Peter Hoonakker; Vaibhav Agrawal; Peter Kleinschmidt; Jason Stamm; Douglas Wiegmann; Brian W Patterson
Journal:  Ergonomics       Date:  2019-04-30       Impact factor: 2.778

4.  Low anti-Factor Xa level predicts 90-day Symptomatic Venous Thromboembolism in Surgical Patients Receiving Enoxaparin Prophylaxis: A Pooled Analysis of Eight Clinical Trials.

Authors:  Christopher J Pannucci; Kory I Fleming; Thomas K Varghese; John Stringham; Lyen C Huang; T Bartley Pickron; Ann Marie Prazak; Corinne Bertolaccini; Arash Momeni
Journal:  Ann Surg       Date:  2020-10-19       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.